Plain-English translation of NCT07444957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a special balloon catheter coated with the medication sirolimus (SeQuent® Sirolimus-Coated Balloon) that doctors use to open blocked arteries in the heart. Instead of leaving a permanent stent in place, this coated balloon delivers medicine directly to the blocked area to prevent it from narrowing again. The study will follow patients for up to 3 years to see how safe and effective this treatment is in real-world practice.
Many patients with blocked heart arteries need treatment to restore blood flow, but current options have tradeoffs—some require permanent metal stents that can cause problems later, while others may not prevent the artery from narrowing again. This study aims to see whether this medication-coated balloon offers a safer, simpler alternative that works just as well.
You likely qualify if…
You likely don't qualify if…
If you qualify, your doctor will perform a standard heart catheterization procedure using the special sirolimus-coated balloon to open your blocked artery instead of placing a permanent stent. You will then be followed with visits and heart imaging at regular intervals—at 12 months and up to 36 months—to monitor how well the treatment works and check for any complications. You'll also be asked about any symptoms or heart-related events during this follow-up period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain